Saul E. Rivkin
Impact in
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Research top 1%
- Breast Cancer Treatment Studies
Papers in
- Oncology 76
- Cancer Treatment and Pharmacology 27
- Lung Cancer Research Studies 12
- Pancreatic and Hepatic Oncology Research 11
-
- Lung Cancer Treatments and Mutations 13
- Co-authors
- S P Balcerzak (5 shared papers)Barth Hoogstraten (8 shared papers)Robert M. OʼBryan (9 shared papers)Laurence H. Baker (5 shared papers)John Crowley (4 shared papers)Geoffrey R. Weiss (4 shared papers)Bart Barlogie (3 shared papers)John J. Crowley (6 shared papers)
- Journals
- Journal of Clinical Oncology (36 papers)Cancer (24 papers)Investigational New Drugs (8 papers)Blood (3 papers)Journal of Neuro-Oncology (3 papers)
- Partner nations
- United StatesEgyptCanada
In The Last Decade
Saul E. Rivkin
125 papers receiving 5.5k citations
Saul E. Rivkin's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 3.6k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 2.0k
- Pathology and Forensic Medicine 815
- Reproductive Medicine 352
Countries citing papers authored by Saul E. Rivkin
This map shows the geographic impact of Saul E. Rivkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saul E. Rivkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saul E. Rivkin more than expected).
Fields of papers citing papers by Saul E. Rivkin
This network shows the impact of papers produced by Saul E. Rivkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saul E. Rivkin. The network helps show where Saul E. Rivkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Saul E. Rivkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 Hit paper breakdown → | 2010 | 500 |
| 2 | 1993 | 358 | |
| 3 | 1977 | 300 | |
| 4 | 1992 | 272 | |
| 5 | 2007 | 179 | |
| 6 | 1972 | 167 | |
| 7 | 1999 | 162 | |
| 8 | 1984 | 150 | |
| 9 | 1999 | 142 | |
| 10 | 1987 | 140 | |
| 11 | 2004 | 133 | |
| 12 | 1976 | 127 | |
| 13 | 1997 | 125 | |
| 14 | 2003 | 124 | |
| 15 | Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. | 1976 | 114 |
| 16 | 2001 | 101 | |
| 17 | 1995 | 94 | |
| 18 | 2005 | 91 | |
| 19 | 2004 | 91 | |
| 20 | 1994 | 82 |
About Saul E. Rivkin
Saul E. Rivkin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Reproductive Medicine, having authored 127 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (27 papers), Breast Cancer Treatment Studies (23 papers), Ovarian cancer diagnosis and treatment (22 papers), Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (2.0k citations), Pathology and Forensic Medicine (815 citations) and Reproductive Medicine (352 citations). Saul E. Rivkin has collaborated with scholars based in United States, Egypt and Canada. Frequent co-authors include S P Balcerzak, Barth Hoogstraten, Robert M. OʼBryan, Laurence H. Baker, John Crowley, Geoffrey R. Weiss, Bart Barlogie, John J. Crowley, Thomas E. Moon and Peter M. Ravdin. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Investigational New Drugs, Blood and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.